Compare ARK Genomic Revolution ETF (ARKG) vs Vanguard S&P 500 Growth Index Fund ETF (VOOG) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Vanguard S&P 500 Growth Index Fund ETF — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while Vanguard S&P 500 Growth Index Fund ETF trades at $82.9. Which is the better fit depends on your goals.
| ARKG | VOOG | |
|---|---|---|
Sector | Sector/Thematic | Broad Market / Factor |
52-Week High | $43.57 | $85.11 |
52-Week Low | $23.09 | $65.32 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
VOOG trades at $83.31, up 0.6% today, with a bullish technical outlook supported by moving averages and proximity to resistance at $84. The ETF completed a 1:6 stock split in April 2026 to enhance accessibility and maintains a low 0.07% expense ratio. Recent news highlights its strong growth focus and comparisons with peer ETFs.
Outlook remains positive given growth stock exposure and cost efficiency, though concentration in technology sectors poses volatility risks. The dividend of $0.09 per share scheduled for June 2026 adds income appeal. Investors should weigh sector diversification against potential AI-driven growth opportunities.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Vanguard S&P 500 Growth Index Fund ETF
VOOG is an index-based ETF that tracks the S&P 500 Growth Index, composed of the growth-oriented companies within the S&P 500. It selects constituents based on three key metrics—sales growth, the ratio of earnings change to price, and momentum—offering a highly liquid and low-cost way to capture the high-performing 'growth slice' of the broader U.S. large-cap market.
Read more on VOOG →
